SynthesisJournal of managed care & specialty pharmacy2025

Impact of CDK4/6 inhibitors on health-related quality of life outcomes in patients with metastatic breast cancer: A systematic review and meta-analysis.

Takako Kiener et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.